About this trial
This study is evaluating whether pairing vagus nerve stimulation (VNS) with structured upper limb rehabilitation therapy can improve arm and hand function in individuals with chronic moderate to severe traumatic brain injury (TBI) and subsequent motor deficits.
Many people who survive a TBI experience long-term weakness, poor coordination, and difficulty using one arm or hand. These motor impairments can significantly affect independence and quality of life. Traditional rehabilitation can help, but recovery is often incomplete.
Vagus nerve stimulation (VNS) is an FDA-approved therapy for certain neurological conditions and involves a small device implanted under the skin in the chest with a lead connected to the vagus nerve in the neck. The device delivers mild electrical pulses to the nerve. In this study, VNS will be paired with goal-directed upper limb rehabilitation exercises. The stimulation is delivered during specific movements in therapy sessions. This "paired stimulation" approach is designed to enhance neuroplasticity - the brain's ability to reorganize and form new connections - which may improve motor recovery.
The VNS device used in this study is FDA-approved for other conditions. However, its use paired with rehabilitation for upper limb recovery after traumatic brain injury is investigational.
Participants in this study will:
Undergo surgical implantation of the VNS device.
Participate in structured upper limb rehabilitation therapy sessions where stimulation is paired with specific movements.
Complete follow-up visits and assessments to measure changes in arm and hand function, strength, dexterity, and overall recovery.
The main goal of the study is to determine whether paired VNS and rehabilitation improves upper limb motor function compared to rehabilitation alone. Safety will also be closely monitored, including surgical outcomes and any device-related effects.
This study may help determine whether VNS paired with rehabilitation is a safe and effective way to enhance motor recovery after traumatic brain injury. Findings from this research could contribute to improved treatment strategies for individuals living with long-term motor impairments following TBI. If the results are promising, future studies plan to also include patients with acute TBI.
Participation is voluntary. All participants will be carefully evaluated to determine eligibility, and informed consent will be obtained before enrollment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 22-80 years
History of severe TBI (initial GCS ≤ 8)
Regained consciousness with capacity to consent to the study
At least six months since injury
Disqualifiers
No capacity to consent to the study
History of stroke
History of cognitive disorder or other neurodegenerative disorder
History of epilepsy treated by VNS
Trial design
Single group
Treatments tested in this trial
VNS for TBI group
DeviceGroup will be implanted with VNS device for chronic TBI
Treatment groups
Trial outcomes
Primary outcomes
Number of Participants With Device- or Procedure-Related Adverse Events
Adverse events related to VNS device implantation or stimulation will be recorded and graded using CTCAE v5.0.
Change in Upper Limb Range of Motion as Assessed by SeeMe Movement Analysis
Video-based kinematic analysis of upper limb range of motion, comparing baseline (pre-surgery) to post-training (6 weeks after VNS-paired rehabilitation).
Secondary outcomes
Change in Disability Rating Scale (DRS) Score
RS score (range 0 \[no disability\] to 29 \[extreme vegetative state\]; lower scores indicate better outcome). Magnitude of change will be used to estimate effect size for power calculation in a future multicenter randomized trial.
Change in Coma Recovery Scale-Revised (CRS-R) Score
CRS-R total score (range 0-23; higher scores indicate better neurobehavioral function), comparing baseline to post-training.
Change in Wolf Motor Function Test (WMFT) Performance Time
Time (seconds) to complete standardized WMFT tasks; lower time indicates better function. Comparing baseline to post-training.
Change in Fugl-Meyer Assessment Upper Extremity (FMA-UE) Score
FMA-UE score (range 0-66; higher scores indicate better motor function), comparing baseline to post-training.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Stony Brook University
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: